Authors:
RASKIN P
GANDA OP
SCHWARTZ S
WILLARD D
ROSENSTOCK J
LODEWICK PA
CRESSMAN MD
PHILLIPSON B
WEINER B
MCGOVERN ME
NORTON JM
CUCINOTTA GG
BEHOUNEK BD
Citation: P. Raskin et al., EFFICACY AND SAFETY OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, The American journal of medicine, 99(4), 1995, pp. 362-369
Authors:
BEHOUNEK BD
MCGOVERN ME
KASSLERTAUB KB
MARKOWITZ JS
BERGMAN M
BEDARD J
LEITER L
OLEARY TJ
TAN MH
TILDESLEY HD",BERTHEZENE,KREMPF,MOINADE,PASSA,WEMEAU,BIESENBACH,DAMMANN,ERHARD,HEBBELN,HUTH,MAHLA,MARTENS,PATSCH,SCHNEIDER,SCHOLTEN,TEUBER,WEISWEILER,"BARON H",KLEINMAN,"SEGAL P
YESHURON D
AWUNORRENNER C
CONALGEN JC
FEEK CM
Citation: Bd. Behounek et al., A MULTINATIONAL STUDY OF THE EFFECTS OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, Clinical cardiology, 17(10), 1994, pp. 558-562
Authors:
SANTINGA JT
ROSMAN HS
RUBENFIRE M
MACIEJKO JJ
KOBYLAK L
MCGOVERN ME
BEHOUNEK BD
Citation: Jt. Santinga et al., EFFICACY AND SAFETY OF PRAVASTATIN IN THE LONG-TERM TREATMENT OF ELDERLY PATIENTS WITH HYPERCHOLESTEROLEMIA, The American journal of medicine, 96(6), 1994, pp. 509-515
Authors:
RASKIN P
GANDA OP
SCHWARTZ S
WILLARD D
LODEWICK P
CRESSMAN M
PHILLIPSON B
WEINER B
BEHOUNEK BD
Citation: P. Raskin et al., PRAVASTATIN SIGNIFICANTLY IMPROVES THE LIPID RISK-FACTORS FOR CORONARY-DISEASE IN DIABETIC-PATIENTS WITH HYPERCHOLESTEROLEMIA, Diabetes, 42, 1993, pp. 236-236
Authors:
BEHOUNEK BD
MARKOWITZ JS
BERGMAN M
MCGOVERN ME
KASSLERTAUB KB
VANHANEN H
ELORANTA M
JUVONEN J
KANTOLA I
KEKKI S
KIVELA H
KNUTAR F
NISSEN M
SALMI J
SALONEN R
TARPILA S
TUNTURIHIHNALA H
AMANN FW
BERENDES G
BONNER G
DUBACH UC
EGGSTEIN M
FRANKENBERG HV
FROER KL
HOHL H
HOPPE F
KUMMER H
MARZ W
MOCCETTI T
NOSEDA G
REUTTER FW
SCHWENKE R
VOSSCHULTE G
WAMBACH G
WEIDMANN P
BONNIER JJRM
DEWEERD P
HUIGE MC
JANSEN LJ
TERIJDT AJ
TEVELDE K
OLSSON AG
LARSSON H
ASPLUND J
DAHLQVIST A
LONNQVIST F
FRITHZ G
HOGLUND C
KJELLSTROM T
KUYLENSTIERNA J
MOLLER B
OSTERGREN J
CRAMB R
DAVIES J",IVERSON,"JOHNSTON GD
MUNRO A
PEACOCK I
RITCHIE LD
RITTER J
RYLANCE PB
SEVER PS
SIMMONS RL
Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037